Stryker Corporation (SYK) Stock
NYSESYK has an Alpha Score of 43 out of 100 (weak), computed on Oct 27, 2026 from 3 of 4 sub-scores. 21 members of Congress disclosed 72 trades in SYK since 2014: 22 purchases and 50 sales, most recently Thomas H. Kean (partial sale, Jul 22, 2026). 7 of the hedge funds AlphaScala tracks reported SYK in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Fundsmith's at $917.39M. Company insiders reported 0 open-market buys and 22 sales on SEC Form 4 in the 90 days to Oct 30, 2026. Its trailing P/E ratio is 31.1 and its net margin 14.4% (key statistics as of Oct 29, 2026).
What is SYK's Alpha Score?
How it works →Alpha Score of 43 reflects weak overall profile with moderate momentum, poor value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 27, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded Stryker Corporation (SYK)?
Most recent: Thomas H. Kean (partial sale, Jul 22, 2026); records start Jun 16, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Tom Kean Jr. R-NJ · House | 2026-07-22 | partial sale | $1k – $15k |
| Tom Kean Jr. R-NJ · House | 2026-06-02 | partial sale | $1k – $15k |
| Alan Armstrong R-OK · Senate | 2026-03-27 | sale | $15k – $50k |
| Tom Kean Jr. R-NJ · House | 2026-01-23 | partial sale | $15k – $50k |
| Gil Cisneros D-CA · House | 2025-12-10 | purchase | $1k – $15k |
| Tom Kean Jr. R-NJ · House | 2025-11-20 | partial sale | $15k – $50k |
| Gil Cisneros D-CA · House | 2025-11-18 | purchase | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-10-17 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
Every member of Congress who traded SYK, with filing lags →Which hedge funds own SYK?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Fundsmith Terry Smith | 2.91M | $917.39M | -5% |
| Point72 Steve Cohen | 430K | $135.41M | +1604% |
| D.E. Shaw David Shaw | 271K | $85.18M | -55% |
| Citadel Ken Griffin | 152K | $48.00M | -0% |
| Millennium Management Israel Englander | 93K | $29.14M | +244% |
| Renaissance Technologies Jim Simons (founder) | 91K | $28.74M | -77% |
| Marshall Wace | 51K | $16.09M | -92% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Stryker Corporation insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 21, 26 | Crotty Dylan Bram | Group President | SELL | 441 | $145K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 40 | $13K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 440 | $147K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 200 | $67K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 80 | $27K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 320 | $108K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 2.3K | $780K |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 11.3K | $3.8M |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 10.8K | $3.7M |
| Aug 19, 26 | Stryker Ronda E | Director | SELL | 16.6K | $5.7M |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are SYK's key statistics?
Key statistics as of Oct 29, 2026
How does SYK's valuation compare with the Healthcare sector?
| Metric | SYK | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 31.1 | 27.1 | 97 |
| Net margin | 14.43% | 5.48% | 139 |
| Return on equity | 16.36% | 6.84% | 158 |
| Dividend yield (payers) | 1.02% | 1.62% | 50 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
SYK price chart
Powered by TradingViewWhat does Stryker Corporation do?
Stryker Corporation is a medical technology company that designs, manufactures, and markets innovative products and services to improve patient and healthcare outcomes worldwide. It operates primarily through two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. The MedSurg and Neurotechnology segment provides surgical equipment, navigation systems, endoscopic and communications systems, patient handling and emergency medical equipment, intensive care disposables, clinical communication and workflow solutions, and products for treating acute ischemic and hemorrhagic stroke, as well as traditional brain and open skull-based surgical procedures, orthobiologics, and biosurgery. The Orthopaedics and Spine segment offers implants for hip and knee joint replacements, trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems for spinal injury, deformity, and degenerative therapies. Stryker Corporation also features orthopedic robotics and minimally invasive solutions. Founded in 1941 and headquartered in Portage, Michigan, it serves healthcare providers globally across hospitals, surgical centers, and emergency settings, holding leadership positions in reconstructive orthopedic implants and operating room equipment.